-
8:30AM - 10:30AM EDT Delta Hotel
Plenary Session I
Ashish Shah, Vanderbilt University
Dr. Ashish S. Shah is the Alfred Blalock Director and Chair of Cardiac Surgery at Vanderbilt University Medical Center. He trained at Duke University Medical Center and served on the faculty of The Johns Hopkins Hospital for 10years before joining the faculty at Vanderbilt.
Matthew Hartwig, Duke Hospital
Dr. Hartwig is a tenured Professor of Surgery within the Division of Thoracic and Cardiovascular Surgery at Duke University School of Medicine. He has particular clinical interests in lung transplantation, disorders of the esophagus, and robotic technology utilization in thoracic surgery.
-
10:30AM - 11:45AM EDT Delta Hotel
Concurrent Session A: Heart - Challenging MCS and Heart Transplant
Pedro Catarino, Cedars Sinai Medical Center
Pedro Catarino is a Professor of Cardiac Surgery and Director of Aortic Surgery at Cedars-Sinai Medical Center, Los Angeles. He graduated from Oxford University Medical School; then trained in cardiothoracic surgery at the Royal Brompton Hospital in London, and was a transplant fellow at Duke. He was a consultant surgeon at the Royal Papworth Hospital in Cambridge, England where he was Director of Heart and Lung Transplant and MCS, until moving to his current position in the USA in 2020. At Papworth he was responsible for what was the largest volume DCD heart transplant program in the world, and he oversaw the establishment of a national procurement service for DCD hearts for the UK, incluing for pediatric use. Currently, he is particularly involved in minimally invasive lung transplantation and lung transplant post-COVID.
- Moderator: Pedro Catarino, Cedars Sinai Medical Center
-
10:30AM - 11:45AM EDT Delta Hotel
Concurrent Session B: Lung - Lung Preservation and PGD (NON CME)
-
1:30PM - 2:45PM EDT Delta Hotel
Concurrent Session C: Heart - Limits to DCD Heart Transplant
Nader Moazami, New York University
Nader Moazami, MD is the Surgical Director of Heart Transplantation and Mechanical Circulatory support at NYU Langone Health. Dr. Moazami is a graduate of the Columbia University College of Physicians and Surgeons, New York. He served his internship and residency at Columbia-Presbyterian Medical Center in New York, and completed a fellowship in cardiothoracic surgery at Cleveland Clinic in 2001. His major areas of focus have been in Mechanical Circulatory Support and more recently on Heart transplantation.
A prolific researcher, Dr. Moazami has published more than 100 scientific articles in leading peer-reviewed journals. He has been the principal investigator on over two dozen trials of new heart assist devices and other therapies for end-stage heart failure. Additionally he serves as a reviewer for several of the heart and transplantation journals.
Dr. Moazami is a frequent speaker and instructor with more than 200 presentations and educational sessions to his credit. His professional memberships include the International Society for Heart & Lung Transplantation, Society of Thoracic Surgeons, Heart Failure Society of America, American Society for Artificial Internal Organs and American Association for Thoracic Surgery. His professional career has been dedicated to advancing the field of mechanical circulatory support and heart transplantation. His most recent accomplishments are in areas of expanding the donor pool for heart transplantation using NRP for DCD heart donations, use of hepatitis C viremic donor hearts, and ethical aspects of NRP. In summer of 2022, his team was the first in the world to complete pig-human xenotransplantation in 2 recently deceased recipients who donated their body to research.
- Moderator: Nader Moazami, New York University
-
1:30PM - 2:45PM EDT Delta Hotel
Concurrent Session D: Lung - DCD
-
3:15PM - 5:00PM EDT Delta Hotel
Plenary II: Innovation and MCS
Marcelo Cypel, University Health Network
Marcelo Cypel MD, MSc, FACS, FRCSC
Surgical Director Ajmera Transplant Centre at UHN
Surgical Director UHN ECLS Program
Canada Research Chair in Lung Transplantation
Professor of Surgery, Division of Thoracic SurgeryUniversity of Toronto, University Health Network
Senior-Scientist, Toronto General Research Institute
Shaf Keshavjee, University Health Network
Dr. Shaf Keshavjee completed his medical training at the University of Toronto in 1985, and subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation, respectively. He leads a team whose studies in transplantation have had a significant impact on treatment outcomes for patients with lung disease around the world. Dr. Keshavjee is currently Chief of Innovation at University Health Network, University of Toronto.
An integral part of the Division of Thoracic Surgery at UHN, Dr. Keshavjee has taken on leadership roles in all facets of this specialized area of care: as a skilled surgeon and Director of the Toronto Lung Transplant Program; and as a researcher and Director of the Latner Thoracic Research Laboratories. To improve lung function after transplantation, he developed a lung preservation solution to preserve donor lungs for transplant. This solution has become the standard technique used by transplantation programs around the world. Dr.Keshavjee has further attracted worldwide attention for his pioneering research to recondition and repair injured human donor lungs using gene and cell therapies and the Toronto Ex Vivo Lung Perfusion System, making them suitable for transplantation into patients and enhancing the number of donor lungs available.
Dr. Keshavjee has served on the Board of Directors of the ISHLT and the Canadian Society of Transplantation. He has served as a Member of the Board, Treasurer and then the 102nd President of the AATS. He has received numerous awards and honorary fellowships for his continuing contributions to his field, including several lifetime achievement awards. Dr. Keshavjee has recieved several honorary doctoral degrees, the Order of Ontario, and Canada's highest civilian honor as Officer of the Order of Canada for his contributions to medicine.
-
5:00PM - 6:30PM EDT Delta Hotel
Welcome Reception and Poster Viewing I Sponsored By: Lung Bioengineering